CE4 - Cost-Effectiveness Analysis of Obinutuzumab Associated to Chlorambucil for the Treatment of Slow-Go Patients with Chronic Lymphocytic Leukemia (CLL) Under the Brazilian Public Healthcare System
- Resource Type
- Abstract
- Source
- In
Value in Health October-November 2017 20(9):A855-A855 - Subject
- Language
- ISSN
- 1098-3015